Viewing Study NCT00002632


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-04-12 @ 11:55 AM
Study NCT ID: NCT00002632
Status: COMPLETED
Last Update Posted: 2023-06-15
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV salivary gland cancer View
None recurrent salivary gland cancer View
None high-grade salivary gland mucoepidermoid carcinoma View
None salivary gland adenocarcinoma View